Examkin

Question

Difficulty: MediumPsychopharmacology and Psychological Therapies

A psychiatric consultation is requested for a 31-year-old male inpatient admitted to the medical intensive care unit. The patient was transferred from an outpatient psychiatric facility after developing severe muscle stiffness, diaphoresis, and altered mental status. He has a history of schizoaffective disorder and was recently prescribed fluphenazine. Current vital signs include a pulse of 115/min, blood pressure of 165/95 mmHg, and a temperature of 39.1°C (102.4°F). Physical examination reveals mutism and profound 'lead-pipe' rigidity. Laboratory evaluation reveals a significantly elevated serum creatine kinase level. The diagnosis of neuroleptic malignant syndrome (NMS) is established.

Arrange the following clinical interventions in the correct chronological sequence for managing this patient's condition, from the most immediate initial step to the final long-term management step.

  1. 1Discontinue the fluphenazine therapy.
  2. 2Initiate aggressive supportive care with intravenous fluids and cooling measures.
  3. 3Administer a targeted pharmacologic reversal agent such as bromocriptine or dantrolene.
  4. 4Observe a minimum two-week washout period before cautiously introducing an alternative, lower-risk antipsychotic.

Answer

The correct sequence for managing neuroleptic malignant syndrome is: 1) Discontinue the offending agent, 2) Initiate aggressive supportive care, 3) Administer targeted pharmacologic therapy for refractory/severe cases, and 4) Observe a minimum two-week washout period prior to antipsychotic rechallenge.
The standard of care for neuroleptic malignant syndrome strictly follows a sequence prioritizing the removal of the inciting agent, followed by physiological rescue via supportive care. Pharmacologic treatments (dopamine agonists like bromocriptine/amantadine, or ryanodine receptor antagonists like dantrolene) are reserved for cases that are severe or unresponsive to supportive measures. Finally, long-term management requires a mandatory waiting period of at least two weeks before any careful re-exposure to dopamine antagonists.

Step-by-Step Solution

1
Identify the primary cause of the life-threatening condition and remove it.
Discontinuation of fluphenazine.
Continuing the dopamine antagonist will exacerbate the central dopamine blockade driving the syndrome.
2
Stabilize the patient's acute physiological derangements.
Administration of intravenous fluids and cooling measures.
Rhabdomyolysis and severe hyperthermia can rapidly lead to acute renal failure and cardiovascular collapse without immediate supportive care.
3
Provide definitive medical therapy if supportive care is insufficient.
Administration of bromocriptine or dantrolene.
These agents directly counteract the dopamine blockade or muscle rigidity driving the hypermetabolic state in severe cases.
4
Plan for long-term psychiatric management after stabilization.
Two-week washout period before rechallenge.
Reintroducing antipsychotics too quickly carries a high risk of NMS recurrence; a two-week minimum ensures full clearance of the previous agent and physiological reset.

Key Concept

Stepwise clinical management algorithm for Neuroleptic Malignant Syndrome (NMS).
Estimated Time:1m 0s
Rate this question

Topics

Psychopharmacology and Psychological Therapies

More questions from this topic